Related Experiment Video
Updated: Oct 6, 2025

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
Published on: August 28, 2012
The Evolution of Ovarian Carcinoma Subclassification
Martin Köbel1, Eun Young Kang1
1Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB T2N 2T9, Canada.
Ovarian carcinoma histotypes are classified using morphology and immunohistochemistry. Molecular subtypes offer prognostic insights, guiding future targeted therapies for improved patient outcomes.
Area of Science:
- Gynecologic Pathology
- Oncology
- Molecular Diagnostics
Background:
- Histotype classification is crucial for ovarian carcinoma subtyping, evolving with WHO classifications.
- The fifth edition (2020) recognizes five principal histotypes: high-grade serous carcinoma (HGSC), low-grade serous carcinoma (LGSC), mucinous carcinoma (MC), endometrioid carcinoma (EC), and clear cell carcinoma (CCC).
Purpose of the Study:
- To review the current histotype classification of ovarian epithelial neoplasms.
- To highlight the role of immunohistochemistry and molecular subtyping in diagnosis and prognosis.
- To identify areas for future research in targeted therapies.
Main Methods:
- Morphological assessment based on the WHO Classification of Female Genital Tumours.
- Application of a four-marker immunohistochemical panel (WT1/p53/napsin A/PR) for histotype differentiation.
- Analysis of molecular subtypes and predictive biomarkers for HGSC, EC, CCC, and LGSC.
Main Results:
- A four-marker immunohistochemical panel accurately distinguishes the five principal ovarian carcinoma histotypes.
- Molecular subtyping has advanced for HGSC and EC, showing prognostic relevance.
- Molecular subtypes for clear cell carcinoma (CCC) remain largely undefined, while LGSC shows potential for five prognostic subtypes.
Conclusions:
- Histotype classification, supported by immunohistochemistry and molecular profiling, is essential for understanding ovarian carcinoma.
- Further research into molecular subtypes, particularly for CCC, is needed.
- Development of targeted therapies based on molecular alterations is a critical future direction.
Related Concept Videos
Classification of Epithelial Tissues: Overview
Based on the number of cell layers,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Classification of Epithelial Tissues: Stratified Epithelium
Cancers Originate from Somatic Mutations in a Single Cell
Oogenesis
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

